CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113516358
- Phone
- (984) 884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- 424B5 Offering Prospectus
- SC 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 8-K Event Agreement ended · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Shareholder vote results
- 10-Q Report Quarterly Report
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change · Bylaws or fiscal year change
- 10-K Report Annual Report
Page 39 of 54 · 1,070 filings